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The peptidylarginine deiminase 
gene is a conserved feature of 
Porphyromonas gingivalis
Giorgio Gabarrini1,*, Menke de Smit1,*, Johanna Westra2, Elisabeth Brouwer2, Arjan Vissink3, 
Kai Zhou4, John W. A. Rossen4, Tim Stobernack4, Jan Maarten van Dijl4 & Arie Jan van 
Winkelhoff1,4
Periodontitis is an infective process that ultimately leads to destruction of the soft and hard tissues 
that support the teeth (the periodontium). Periodontitis has been proposed as a candidate risk factor 
for development of the autoimmune disease rheumatoid arthritis (RA). Porphyromonas gingivalis, a 
major periodontal pathogen, is the only known prokaryote expressing a peptidyl arginine deiminase 
(PAD) enzyme necessary for protein citrullination. Antibodies to citrullinated proteins (anti-
citrullinated protein antibodies, ACPA) are highly specific for RA and precede disease onset. Objective 
of this study was to assess P. gingivalis PAD (PPAD) gene expression and citrullination patterns in 
representative samples of P. gingivalis clinical isolates derived from periodontitis patients with and 
without RA and in related microbes of the Porphyromonas genus. Our findings indicate that PPAD is 
omnipresent in P. gingivalis, but absent in related species. No significant differences were found in 
the composition and expression of the PPAD gene of P. gingivalis regardless of the presence of RA or 
periodontal disease phenotypes. From this study it can be concluded that if P. gingivalis plays a role 
in RA, it is unlikely to originate from a variation in PPAD gene expression.
Periodontitis is an infective process that ultimately leads to the destruction of the soft and hard tissues 
that support the teeth (the periodontium). Periodontitis has been proposed as a candidate risk factor 
for rheumatoid arthritis (RA)1. One of the biologically plausible causal mechanisms accounting for the 
association between periodontitis and RA could be induction of RA-related autoimmunity at inflamed 
mucosal sites, e.g. the periodontium2.
Antibodies against citrullinated proteins (ACPA) are highly specific (98%) for RA3 and can precede 
the clinical onset of RA4. Citrullination is a post-translational modification catalyzed by a family of 
enzymes called peptidylarginine deiminases (PAD)5. In this reaction, an arginine residue within a protein 
is converted into the non-coded amino acid citrulline. This modification leads to a loss of positive charge, 
reduction in hydrogen-bonding ability and subsequently in conformational and functional changes of 
the protein.
Porphyromonas gingivalis is a major periodontal pathogen involved in destructive periodontal dis-
ease6 and is the only known prokaryote expressing a PAD enzyme7. P. gingivalis PAD (PPAD) is both a 
secreted and a cell or membrane vesicle associated enzyme7. In contrast to human PAD, PPAD is able to 
modify free arginine and is not dependent on calcium7,8. Citrullination by PPAD enhances the surviva-
bility and increases the fitness of P. gingivalis due to several immune defense mechanisms. Additionally, 
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a side effect of citrullination is ammonia production, which has a negative effect on neutrophil func-
tion and is protective during the acidic cleansing cycles of the mouth7,8. PPAD is regarded as a viru-
lence factor because citrullination by PPAD interferes with complement activity9, inactivates epidermal 
growth factors10 and contributes to infection of gingival fibroblasts and induction of the prostaglandin 
E2 synthesis11. Moreover, PPAD has been reported to be able to generate citrullinated forms of various 
arginine-containing proteins and peptides8, among which are human fibrinogen and human α -enolase, 
two candidate auto-antigens in RA12.
A role of PPAD in autoimmunity is conceivable, considering that citrullinated host peptides generated 
by P. gingivalis are likely to expose epitopes previously hidden to the immune system, which may trig-
ger an immune response in a genetically susceptible host13. In fact, cross reactivity has been shown for 
human antibodies against recombinant CEP-1, an immunodominant epitope of human α -enolase, with 
P. gingivalis enolase14. Moreover, there is strong animal experimental evidence supporting the theory that 
PPAD is the key player linking periodontitis and arthritis15,16.
Whether expression of PPAD is ubiquitous in P. gingivalis and whether there are different forms of 
the gene among P. gingivalis isolates from clinically different donors is currently unknown. Among oral 
bacteria, citrullination of endogenous proteins has only been shown in the P. gingivalis wild-type strain 
W83 and four clinical isolates from patients with periodontitis without RA12. Related species such as 
Porphyromonas endodontalis, indigenous to the oral cavity, and Porphyromonas asaccharolytica, com-
monly found in the gastrointestinal tract, have not been tested for citrullination capacity.
The aim of this study was to assess expression of the PPAD-encoding gene in representative samples 
of P. gingivalis clinical isolates from patients with and without RA, as well as in related species of the 
genus Porphyromonas and in the periodontal pathogens Prevotella intermedia and Fusobacterium nucle-
atum. Additionally, variation in gene composition was analyzed using a combination of primer sets for 
the whole gene and for a region including the active site of the gene, by restriction enzyme analysis of 
the PCR products with three different restriction enzymes, and by whole gene sequencing. Functional 
analysis of PPAD was carried out by assessment of endogenous citrullination patterns.
Methods
PPAD. Bacterial strains and culture conditions. Twelve P. gingivalis strains were isolated from 12 
consecutive patients with RA and periodontitis, participants of an observational study on periodontitis 
and RA17. Eighty P. gingivalis strains were isolated from 80 consecutive subjects without RA (non-RA) 
with various periodontal diagnoses (periodontitis (n = 75), peri-implantitis (n = 2), gingivitis (n = 1) or 
a healthy periodontium (healthy carriers, n = 2), recruited for the control group of the same observa-
tional study17. This study was approved by the Medical Ethics Committee of the University Medical 
Center Groningen (METc UMCG 2011/010), and conducted in accordance with the guidelines of the 
Declaration of Helsinki and the institutional regulations. Written informed consent was obtained from 
all patients. Of note, this study only involved the collection of bacteria; the actual experiments did not 
involve human subjects and no tissue samples were used. Some general characteristics of the subjects 
from whom P. gingivalis was isolated are listed in Table 1. These clinical isolates, the P. gingivalis refer-
ence strains ATCC 33277 and W83, P. asaccharolytica (clinical isolate), P. endodontalis (clinical isolate), 
F. nucleatum (ATCC 25586) and P. intermedia (clinical isolate) were anaerobically grown on blood agar 
plates (Oxoid no. 2, Basingstoke, UK) supplemented with sheep blood (5% v/v), hemin (5 mg/l) and 
menadione (1 mg/l) and incubated in 80% N2, 10% H2 and 10% CO2, at 37 °C6.
DNA extraction. Colonies from a blood agar plate were suspended in 500 μ L Tris-EDTA buffer and bac-
terial DNA was isolated utilizing a Precellys® 24 Technology tissue homogenizer (Bertin Technologies) 
(3 times per 30 sec. at 5000 rpm with 30-sec. breaks in between). Afterwards, samples were boiled for 
10 min. at 95 °C and centrifuged at 16100 g, 4 °C for 10 min. Supernatants were collected and stored at 
− 20 °C. For whole genome sequencing, total DNA was extracted from 7 P. gingivalis strains using the 
Ultraclean Microbial DNA Isolation Kit (MO BIO Laboratories, Carlsbad, CA, US) following the man-
ufacturer’s instructions.
PPAD PCR. PCR was performed on the PPAD gene using Phusion DNA Polymerase 
(Thermoscientific) and two sets of primers. The first pair, P1F and P1R, covered the whole gene 
and the second pair, P2F and P2R, covered a short region around the active site (Cys351). The 
sequence of P1F was 5′ -GGGGAGCTCATGAAAAAGCTTTTACAGGCTAAAGC-3′ while the 
sequence of P1R was 5′ -GGGCTCGAGTTTGAGAATTTTCATTGTCTCACGG-3′ . The sequence 
of P2F was instead 5′ -CTGATTCTGAACAACAGGGT-3′ , while the sequence of P2R was 
5′ -TAAAGCTACCGGAACCATTG-3′ . The samples were denatured at 98 °C for 10 seconds, annealed 
at 56 °C for 20 seconds and extended at 72 °C for 2 minutes for a total of 33 cycles. Analysis was then 
performed using gel electrophoresis on a 1% agarose gel, immersed in SB buffer (10 mM NaOH; 36 mM 
boric acid, pH 8.0) and subjected to 120 V for 30 minutes.
Restriction enzyme analysis. DNA samples for restriction enzyme analysis were cleaved with the 
four-nucleotide cutters Sau3AI, Taqα I or DpnI following the instructions of the supplier (New England 
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Biolabs) (incubation for 90 minutes at 37 °C for Sau3AI and DpnI and at 65 °C for Taqα I, followed by 
heat inactivation for 20 minutes at 80 °C for Taqα I and DpnI and at 65 °C for Sau3AI). Sau3AI and Taqα 
recognize the same sequence (GATC) but cut at different positions while DpnI recognizes TCGA.
Whole genome sequencing and data analysis. DNA was extracted from a representative random sam-
ple of 7 P. gingivalis isolates that had been obtained from two RA patients with severe periodontitis, 
two RA patients with moderate periodontitis, two non-RA patients with severe periodontitis and one 
healthy carrier. The isolates originated from unrelated individuals. The DNA concentration and purity 
were controlled by a Qubit® 2.0 Fluorometer using the dsDNA HS and/or BR assay kit (Life technol-
ogies, Carlsbad, CA, US). The DNA library was prepared using the Nextera XT -v3 kit (Illumina, San 
Diego, CA, US) according to the manufacturer’s instructions and then run on a Miseq (Illumina) for 
generating paired-end 300 bp reads. De novo assembly was performed with CLC Genomes Workbench 
v7.0.4 (Qiagen, Hilden, Germany) after quality trimming (Qs ≥ 20) with optimal word size18. PPAD gene 
sequences were derived from the 7 assembled genomes and from 5 P. gingivalis genomes retrieved from 
GenBank (accession: NC_002950, NC_010729, NC_015571, CP007756 and AJZS01). DNA and amino 
acid sequences of 12 PPAD genes were aligned using the MAFFA v7 web server (http://mafft.cbrc.jp/
alignment/software/). The PPAD gene sequences of strains 20655, 20658, MDS-16, MDS-45, MDS-56, 
MDS-85 and MDS-140 have been deposited at DDBJ/EMBL/GenBank under the accession numbers 
KP862650-KP862656.
Endogenous protein citrullination patters. Bacterial strains and culture conditions. The 12 P. gin-
givalis isolates from patients with RA and 12 randomly selected P. gingivalis isolates from non-RA sub-
jects, and individual clinical isolates of P. asaccharolytica, P. endodontalis and F. nucleatum were analyzed 
for endogenous protein citrullination patterns. The isolated bacterial strains were anaerobically grown 
on blood agar plates (Oxoid no. 2, Basingstoke, UK), which were supplemented with sheep blood (5% 
v/v), hemin (5 mg/L) and menadione (1 mg/L) and incubated in 80% N2, 10% H2 and 10% CO2, at 37 °C.
Bacterial cell lysate preparation. Four-day old colonies of monocultures of the selected bacterial strains 
were suspended in sterile phosphate buffered saline (PBS) with protease inhibitors (Complete Mini 
Protease Inhibitor Cocktail Tablets, Roche Diagnostics, 1 tablet for 7 ml PBS). After washing and cen-
trifugation cycles (3 × 5 min., 14489 g, 4 °C) the bacterial pellets were resuspended in lysis buffer con-
taining non-denaturing detergent (Noninet P-40, Sigma-Aldrich, Inc.) and sonicated on ice for 15 min. 
(Bioruptor® Standard sonication device, Diagenode s.a.). Protein concentration was determined using 
the BCA Protein Assay Kit (Thermo Scientific, Pierce Protein Biology Products).
SDS-PAGE and gel staining. Bacterial cell lysates were prepared with 2× SDS sample buffer (4% SDS, 








RA 12 64 (56–71) 25 75
non-RA 80 51 (42–60) 27 54





*Characteristics of RA patients
median disease duration 
(months, IQR) 37 (27–109)
median DAS28 (IQR) 2.3 (1.6–4.0)
median CRP (mg/l, IQR) 3 (3–14)
anti-CCP seropositive (%) 92
IgM-RF seropositive (%) 92
MTX monotherapy (%) 92
Table 1.  General characteristics of subjects from whom P. gingivalis was isolated. RA: rheumatoid 
arthritis, non-RA: without rheumatoid arthritis, IQR: interquartile range, n: number, DAS28: disease 
activity score 28 tender and swollen joint count, CRP: C-reactive protein, anti-CCP: anti-cyclic citrullinated 
protein antibody, IgM-RF: IgM rheumatoid factor, MTX: methotrexate, *for details see17.
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boiled for 5 min. Per sample, 15 μ g of protein was loaded onto a 12.5% SDS-PAGE gel (Criterion Tris-HCl, 
Bio-Rad Laboratories, Inc.) and resolved by running at 200 V and 15 Watt constant for 1.5 hours. Gels 
were stained using Coomassie® staining (SimplyBlue™ SafeStain, Life Technologies Corporation) or 
transferred to a PVDF membrane (Immobilon® EMD Millipore Corporation, Billerica, MA, USA).
Western Blot. Citrulline-containing proteins were detected by Western blotting with a polyclonal IgG 
antibody (Anti-Citrulline Modified Detection Kit, Upstate, EMD Millipore Corporation, Billerica, MA, 
USA) according to the manufacturer’s instructions. In addition, detection of citrulline containing pro-
teins was done with a monoclonal IgM antibody (F95) against a deca-citrullinated peptide (U2005-
0033, UAB Research Foundation, Birmingham AL) using the following protocol: after blocking for 
one hour using a 1:1 dilution of Odyssey® Blocking Buffer (LI-COR Biosciences, Lincoln, USA) and 
PBS, incubation with F95 in the same blocking buffer (final dilution 1:2000) with 0.1% Tween®20 
(Sigma-Aldrich Co. LLC.) was done overnight at 4 °C. IRDye® 800 conjugated goat anti-mouse IgM 
(Rockland Immunochemicals Inc., Gilbertsville) (1:10000) in Odyssey® Blocking Buffer and PBS (1:4) 
with 0.1% Tween®20 (Sigma-Aldrich Co. LLC.) was used as secondary antibody for one hour at room 
temperature. In vitro citrullinated human fibrinogen (341578, Calbiochem, distributed by VWR inter-
national) by rabbit PAD (P1584, Sigma-Aldrich Co. LLC.) was used as positive control19. Non-specific 
binding of the secondary antibody was excluded by omitting the primary antibody. Protein bands were 
detected by the Odyssey system (LI-COR Biosciences, Lincoln, USA). For graphical reproduction of the 
gels, the signal and size of the protein bands were analyzed using Image Studio Version 2.0.38 (LI-COR 
Biosciences, Lincoln, USA) with the same image display settings per gel. F. nucleatum was considered as 
negative control12 and, if present, the signal of the detected bands was corrected for the mean signal of 
F. nucleatum. The sizes of detected bands were plotted in a graph using GraphPad Prism 5 (GraphPad 
Software Inc.).
Results
PPAD gene is a conserved feature of P. gingivalis. The PPAD gene, consisting of 1668 base pairs, 
was detected by PCR in all 92 investigated P. gingivalis strains, but not in any of the other bacterial species 
tested (Fig. 1A). The same holds true for the region encoding the active site of PPAD, consisting of 328 
base pairs (Fig.  1B). Cleavage of the PCR-amplified PPAD genes with three different restriction endo-
nucleases and subsequent separation of the fragments by gel electrophoresis revealed no differences in 
the respective banding patterns for all 92 investigated P. gingivalis strains (shown for Sau3AI in Fig. 1C). 
Furthermore, no differences in the whole PPAD gene or in the active site-encoding regions of PPAD were 
observed between P. gingivalis isolates from RA patients or P. gingivalis isolates from non-RA patients 
(shown for the whole PPAD gene in Fig. 1D).
Conservation of PPAD gene sequence. Alignment of the PPAD gene sequences of the P. gingivalis 
strains revealed that the PPAD gene is highly conserved among all analyzed strains. At the DNA and 
amino acid level, no mutations were found in the signal peptide region and also the active site Cys351 
residue is strictly conserved. Overall, the PPAD protein of each strain analyzed has no more than five 
different amino acids compared to the PPAD proteins of the reference strains W83 or ATCC 33277. In 
addition, none of the mutations is an insertion, deletion or leads to proteins truncations. However, allelic 
differences were detected in the PPAD gene sequences, especially for the clinical isolates 20655 (derived 
from a non-RA patient with periodontitis) and MDS-85 (derived from an RA patient with periodontitis), 
which displayed 23 and 18 single nucleotide mutations respectively compared to the reference strain 
W83. Table 2 summarizes the number of nucleotides in the PPAD genes and amino acid residues in the 
PPAD proteins that differentiate each strain from any other.
Interestingly, the highest number of identified mutations is 25, which separates the PPAD genes from 
isolates 20655 and 20658 (both derived from non-RA patients with severe periodontitis), and from iso-
lates 20655 (derived from a non-RA patient with severe periodontitis) and MDS-140 (derived from a 
healthy carrier). Notably, besides their low numbers, the majority of these mutations were synonymous. 
Taken together, these results show a very high level of PPAD conservation in the investigated P. gingivalis 
isolates.
Endogenous protein citrullination patterns. To determine possible differences in the protein cit-
rullination activities of different PPAD enzymes both the AMC detection method and the anti-citrulline 
F95 monoclonal antibody were employed. Both assays showed that the patterns of citrullinated proteins 
of P. gingivalis isolates from patients with RA were not detectably different when compared to the pat-
tern of citrullinated proteins from P. gingivalis isolates from non-RA patients. Figure  2 (panels A,C,E) 
shows the Coomassie-stained gel and Western blots for 6 representative P. gingivalis isolates of each 
group, including a graphical representation of the respective citrullination patterns (panels B,D). After 
correction for conjugate controls, P. asaccharolytica and P. endodontalis showed no protein bands with 
the AMC detection method. However, some citrullinated protein bands were observed for these species 
when the F95 antibody was applied. Neither of the two detection methods revealed citrullinated proteins 
in samples of F. nucleatum (Fig. 2, panels A,C).
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Discussion
This is the first study assessing PPAD expression in a large sample of clinical P. gingivalis isolates obtained 
from patients with or without RA. Our findings indicate that PPAD is omnipresent in P. gingivalis, 
but absent from P. endodontalis and P. asaccharolytica as well as from the other periodontal pathogens 
studied.
Our present observations support the view that PPAD may represent one of few, if not the only 
prokaryotic peptidylarginine deiminase. Of note, our analyses show that the PPAD gene is highly con-
served in P. gingivalis. Consequently, the encoded PPAD enzymes share 98.9–100% amino acid sequence 
identity. This may suggest that PPAD contributes to the ability of P. gingivalis to colonize and thrive in 
its human host. Notably, some mutations in PPAD are missense and it may be of interest to analyze the 
citrullination levels of the respective PPAD isotypes, in order to see whether these mutations influence 
the enzymatic activity. Similarly, the mammalian PAD enzyme is also highly conserved with 70–95% 
identical amino acids sequences5; hinting at the importance of protein citrullination for both mammals 
and P. gingivalis, although we found no indications that the PPAD is evolutionarily related to the mam-
malian PAD enzymes20.
Concerning PPAD, no differences were noted in the PPAD genes among P. gingivalis isolates from 
patients with or without RA. Also, no differences in PPAD genes were noted among P. gingivalis isolates 
from patients with different stages of periodontal disease or periodontal health. Therefore, we assume 
that there are no different PPAD variants in P. gingivalis. Functional analysis of PPAD further substanti-
ated this assumption. No differences in endogenous citrullination patterns were seen between P. gingivalis 
Figure 1. PPAD gene composition analyzed by PCR and restriction enzyme analysis of the PCR 
products. (A) PCR products of PPAD obtained with whole-gene primers (1668 base pairs) using 10 
representative P. gingivalis isolates of patients without RA. No PPAD genes are detectable in other 
Porphyromonas species or other selected periodontal pathogens. (B) PCR products of PPAD obtained with 
active site region primers (328 base pairs) of 14 representative P. gingivalis isolates from patients without 
RA. No PPAD genes are detectable in other Porphyromonas species or other selected periodontal pathogens. 
(C) Restriction enzyme analysis with Sau3AI of PPAD PCR products obtained with whole-gene primers 
of 13 representative P. gingivalis isolates from patients without RA. (D) PPAD PCR products obtained with 
whole-gene primers of 14 representative P. gingivalis isolates from patients with or without RA. M = marker 
displayed as number of base pairs (GeneRuler™ 1 kb Plus DNA ladder). C1 = positive control (PPAD of 
P. gingivalis W83). C2 = positive control (PPAD of P. gingivalis ATCC 33277). 1 = P. intermedia, 2 = P. 
asaccharolytica, 3 = P. endodontalis and 4 = F. nucleatum. Digested = PPAD PCR products digested with 
Sau3AI. Undigested = PPAD PCR products of the same 13 P. gingivalis clinical isolates not incubated with 
Sau3AI. non-RA = without rheumatoid arthritis. RA = with rheumatoid arthritis.
www.nature.com/scientificreports/
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MDS-45 MDS-85 MDS-16 MDS-56 20655 20658 MDS-140 W50 HG66 TDC60 W83 ATCC33277
MDS-45 0 10 12 9 19 16 14 13 15 11 12 15
MDS-85 5 0 14 15 21 18 20 19 19 13 18 19
MDS-16 3 4 0 11 19 13 12 13 13 11 12 13
MDS-56 2 5 3 0 20 17 11 10 12 12 9 12
20655 6 7 7 6 0 25 25 24 22 24 23 22
20658 3 4 2 3 5 0 18 17 15 15 16 15
MDS-140 4 5 3 4 8 3 0 13 15 17 12 15
W50 2 5 3 2 6 3 4 0 12 16 1 12
HG66 1 4 2 1 5 2 3 1 0 16 11 0
TDC60 3 6 2 3 7 2 3 3 2 0 15 16
W83 1 4 2 1 5 2 3 1 0 2 0 11
ATCC33277 1 4 2 1 5 2 3 1 0 2 0 0
Table 2.  Representation of the numbers of different nucleotides in PPAD genes and numbers of amino 
acid substitutions in the corresponding PPAD proteins. Top right, number of different nucleotides; bottom 
left, number of amino acid substitutions (italic). PPAD gene sequences from P. gingivalis isolates obtained 
from two RA patients with severe periodontitis (MDS-45, MDS-85), two RA patients with moderate 
periodontitis (MDS-16, MDS-56), two non-RA patients with severe periodontitis (20655, 20658) and one 
healthy carrier (MDS-140). Additional PPAD gene sequences were retrieved from GenBank (W50, HG66, 
TDC60, W83, ATCC 33277).
Figure 2. Patterns of citrullinated proteins of P. gingivalis isolates from patients with or without RA. 
(A,C,E) Western blots and Coomassie staining of bacterial cell lysates of 12 representative P. gingivalis 
isolates of patients with or without RA (both n = 6). (A) Citrullinated protein patterns as detected with  
the AMC detection method (AMC). (C) Citrullinated protein patterns as detected with the F95 anti-
citrulline antibody (F95). (E) Coomassie staining. (B,D) Graphical representation of the Western blots 
shown in panels (A,C). (B) Citrullinated protein patterns as detected with the AMC detection method 
(AMC). (D) Citrullinated protein patterns as detected with the F95 anti-citrulline antibody (F95).  
(F) Graphical representation of citrullinated protein patterns as detected by Western blots using the F95 
anti-citrulline antibody (F95) against bacterial cell lysates of 24 representative P. gingivalis isolates of  
patients with or without RA (both n = 12). The Western blots were analyzed with the same image  
display settings. 1 = Molecular weight marker in kilo Dalton (kDa), 2 = P. asaccharolytica, 3 = P. 
endodontalis, 4 = F. nucleatum, Pg non-RA = P. gingivalis isolates from subjects without RA, Pg RA = P. 
gingivalis isolates of patients with RA. The strong positive staining at circa 120 kDa in P. endodontalis (3) 
both with the AMC and the F95 detection method (panels A,C) is due to non-specific binding of the 
secondary antibody.
www.nature.com/scientificreports/
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isolates from RA and non-RA patients, as determined with two different anti-citrulline antibodies. Some 
differences were observed in the citrullination patterns detected with the two antibodies against citrul-
linated proteins, which can probably be attributed to the monoclonal (F95) or polyclonal (AMC) nature 
and the isotypes of these antibodies (IgM and IgG, respectively). Another difference between the anti-
bodies is the chemical modification of the citrulline residues in the AMC detection method to ensure 
detection of citrulline-containing proteins regardless of neighboring amino acid sequences.
Based on the observations in this study, we conclude that PPAD is apparently omnipresent in P. gingiv-
alis but absent from P. asacharolytica and P. endodontalis, two related species of the genus Porphyromonas. 
There are no significant differences in the PPAD gene regardless of RA or periodontal disease pheno-
types. Therefore, from this study it can be concluded that if P. gingivalis plays a role in RA, it is unlikely 
to originate from a variation in PPAD gene expression.
An important future goal to strive for will be a detailed characterization of the function of the PPAD 
protein and its post-translational modifications. The production of recombinant PPAD in Escherichia coli 
has been studied in order to investigate its protein function. The catalytic mechanism was identified and 
showed different enzyme activities based on an N-terminal truncation of the protein21. This finding is 
in accordance with a recent study by Konig et al. which showed that non-cleaved PPAD is autocitrulli-
nated and has decreased activity22. Additionally, Konig et al. concluded that autocitrullination of PPAD 
is not the underlying mechanism linking P. gingivalis with RA because it does not occur in P. gingiv-
alis cells and patient antibodies were directed specifically against non-citrullinated PPAD. Conversely, 
another recent study showed a peptidyl-citrulline specific antibody response in patients and concluded 
that PPAD autocitrullination is still a potential mechanism for breaching autoimmunity in RA patients20. 
Besides these theories mainly focusing on cleavage and autocitrullination of PPAD, it will be crucial 
to investigate the overall citrullination of bacterial and host proteins by PPAD in especially the in vivo 
situation, as well as the interaction of the human PADs with bacterial proteins, as proposed by Quirke 
et al.20. In conclusion, it is more likely that a difference in post-translational modification of PPAD might 
play an important role in RA, rather than a difference in the PPAD gene.
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